TRICARE getting retroactive rebates
Executive Summary
Manufacturers of drugs dispensed through the TRICARE retail pharmacy program were subject to the ceiling price as of Jan. 28, 2008, and are therefore subject to a refund for the difference in price paid, the Department of Defense says in a March 17 final rule implementing provisions of the National Defense Authorization Act for 2008. Manufacturers may seek a waiver or compromise in the refund amount, but refund payments for utilization data from Jan. 28 through Dec. 31, 2008 are due May 26. Manufacturer groups submitted comments arguing against making the refund retroactive (1"The Pink Sheet," Sept. 29, 2008, p. 13)
You may also be interested in...
Retroactive TRICARE Retail Rebates Could Cause Trouble, PhRMA And BIO Say
BIO and PhRMA are urging the Department of Defense to back down from its proposal to make rebates for drugs filled through the TRICARE retail pharmacy program retroactive to January
Advanz Pharma Agrees Sale In Largest European Deal Since COVID-19 Pandemic
Three years after rebranding from Concordia, Advanz Pharma is to be swallowed up by European-focused private equity Nordic Capital.
Consumer Genome Sequencing Being Applied To Covid-19 New Variants In UK
The goal is to create a program which mass sequences SARS-CoV-2 samples in order to detect new variants, with £30m injected into the UK's hub for genomic sequencing in Cambridge.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: